These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16689921)

  • 1. Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003.
    Vijayaraghavan M; Lievano F; Cairns L; Wolfson L; Nandy R; Ansari A; Golaz A; Mashal T; Salama P
    Disasters; 2006 Jun; 30(2):256-69. PubMed ID: 16689921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide measles vaccination campaign for children aged 6 months-12 years--Afghanistan, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Apr; 52(16):363-6. PubMed ID: 12749476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
    Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.
    Dadgar N; Ansari A; Naleo T; Brennan M; Salama P; Sadozai N; Golaz A; Lievano F; Jafari H; Mubarak M; Hoekstra E; Paganini A; Feroz F
    J Infect Dis; 2003 May; 187 Suppl 1():S186-90. PubMed ID: 12721912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
    Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Grabowsky M; Nobiya T; Selanikio J
    Trop Med Int Health; 2007 Jul; 12(7):815-22. PubMed ID: 17596247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
    Mbabazi WB; Nanyunja M; Makumbi I; Braka F; Baliraine FN; Kisakye A; Bwogi J; Mugyenyi P; Kabwongera E; Lewis RF
    Health Policy Plan; 2009 Jul; 24(4):261-9. PubMed ID: 19282484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimate of the cost/benefit ratio of measles vaccination].
    Cárdenas Ayala VM; Ruiz Matus C; Cabrera Coello L; Montesano Castellanos R; Garrido Lozada MT; Olvera Castillo R; Díaz Ortega JL
    Salud Publica Mex; 1989; 31(6):735-44. PubMed ID: 2516660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI
    J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of outbreak response.
    Jahan S; Al Saigul AM; Abu Baker MA; Alataya AO; Hamed SA
    J Public Health (Oxf); 2008 Dec; 30(4):384-90. PubMed ID: 18716046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Measles Initiative to control measles in Kenya.
    Bradsher CA; Stotts RC; Carter MA; Grabowsky M
    Public Health Nurs; 2007; 24(1):26-33. PubMed ID: 17214650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Philippines 2004 measles campaign: a success story towards elimination.
    Sobel H; Ducusin J; De Quiroz M; Cabotaje M; Olivé JM
    Trop Doct; 2009 Jan; 39(1):36-8. PubMed ID: 19211423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
    Giorgi-Rossi P; Merito M; Borgia P
    Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for measles transmission in England.
    Choi YH; Gay N; Fraser G; Ramsay M
    BMC Public Health; 2008 Sep; 8():338. PubMed ID: 18822142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.